Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Free PDFs: Hepatology 2013 (574 pages) – Hepatitis C 2013 Amedeo Smart: the Smartphone Edition	Free Abstracts

Alzheimer's Disease

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 28 articles: HTML format Text format

Single Articles

March 2013
1. KOZAUER N , Katz R
   Regulatory Innovation and Drug Development for Early-Stage Alzheimer's Disease.
   N Engl J Med. 2013.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2013
2. GRIFFIN WS
   Neuroinflammatory cytokine signaling and Alzheimer's disease.
   N Engl J Med. 2013;368:770-1.
   PubMed     Text format     Related articles   
   
   
   
   January 2013
3. WILLIS MS , Patterson C
   Proteotoxicity and cardiac dysfunction--Alzheimer's disease of the heart?
   N Engl J Med. 2013;368:455-64.
   PubMed     Text format     Related articles   
   
   
   
   
4. LING SM , Bonner AF, McMullen TL
   Discontinuation of risperidone in Alzheimer's disease.
   N Engl J Med. 2013;368:187.
   PubMed     Text format     Related articles   
   
   
   
   
5. POWER GA
   Discontinuation of risperidone in Alzheimer's disease.
   N Engl J Med. 2013;368:186-7.
   PubMed     Text format     Related articles   
   
   
   
   
6. GNJIDIC D , Hilmer SN
   Discontinuation of risperidone in Alzheimer's disease.
   N Engl J Med. 2013;368:186.
   PubMed     Text format     Related articles   
   
   
   
   
7. DEVANAND DP , Schultz SK, Sultzer DL
   Discontinuation of risperidone in Alzheimer's disease.
   N Engl J Med. 2013;368:187-8.
   PubMed     Text format     Related articles   
   
   
   
   December 2012
8. 
   Relapse risk after discontinuation of risperidone in Alzheimer's disease.
   N Engl J Med. 2012;367:2458.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2012
9. LASKE C
   Clinical and biomarker changes in Alzheimer's disease.
   N Engl J Med. 2012;367:2050.
   PubMed     Text format     Related articles   
   
   
   
   
10. PIMPLIKAR SW
    Clinical and biomarker changes in Alzheimer's disease.
    N Engl J Med. 2012;367:2050-1.
    PubMed     Text format     Related articles   
    
    
    
    
11. FLOREZ JC
    Clinical and biomarker changes in Alzheimer's disease.
    N Engl J Med. 2012;367:2051.
    PubMed     Text format     Related articles   
    
    
    
    
12. NEUMANN H , Daly MJ
    Variant TREM2 as Risk Factor for Alzheimer's Disease.
    N Engl J Med. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. GUERREIRO R , Wojtas A, Bras J, Carrasquillo M, et al
    TREM2 Variants in Alzheimer's Disease.
    N Engl J Med. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. JONSSON T , Stefansson H, Ph D SS, Jonsdottir I, et al
    Variant of TREM2 Associated with the Risk of Alzheimer's Disease.
    N Engl J Med. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2012
15. DEVANAND DP , Mintzer J, Schultz SK, Andrews HF, et al
    Relapse risk after discontinuation of risperidone in Alzheimer's disease.
    N Engl J Med. 2012;367:1497-507.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2012
16. YANG L , Rieves D, Ganley C
    Brain amyloid imaging--FDA approval of florbetapir F18 injection.
    N Engl J Med. 2012;367:885-7.
    PubMed     Text format     Related articles   
    
    
    
    August 2012
17. GANDY S
    Lifelong management of amyloid-beta metabolism to prevent Alzheimer's disease.
    N Engl J Med. 2012;367:864-6.
    PubMed     Text format     Related articles   
    
    
    
    
18. LAFERLA FM
    Preclinical success against Alzheimer's disease with an old drug.
    N Engl J Med. 2012;367:570-2.
    PubMed     Text format     Related articles   
    
    
    
    
19. LOWENTHAL J , Hull SC, Pearson SD
    The ethics of early evidence--preparing for a possible breakthrough in Alzheimer's disease.
    N Engl J Med. 2012;367:488-90.
    PubMed     Text format     Related articles   
    
    
    
    July 2012
20. BATEMAN RJ , Xiong C, Benzinger TL, Fagan AM, et al
    Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease.
    N Engl J Med. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2012
21. FINUCANE MM , Finucane TE
    Discontinuing donepezil or starting memantine for Alzheimer's disease.
    N Engl J Med. 2012;366:2227-8.
    PubMed     Text format     Related articles   
    
    
    
    
22. SUZUKI T
    Discontinuing donepezil or starting memantine for Alzheimer's disease.
    N Engl J Med. 2012;366:2227-8.
    PubMed     Text format     Related articles   
    
    
    
    March 2012
23. SCHNEIDER LS
    Discontinuing donepezil or starting memantine for Alzheimer's disease.
    N Engl J Med. 2012;366:957-9.
    PubMed     Text format     Related articles   
    
    
    
    
24. HOWARD R , McShane R, Lindesay J, Ritchie C, et al
    Donepezil and memantine for moderate-to-severe Alzheimer's disease.
    N Engl J Med. 2012;366:893-903.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
25. VAIDYA A , Dolan BM, Edlow BL, Rinne ML, et al
    Interactive medical case. A startling decline.
    N Engl J Med. 2012;366:e11.
    PubMed     Text format     Related articles   
    
    
    
    January 2012
26. MAJOUNIE E , Abramzon Y, Renton AE, Perry R, et al
    Repeat Expansion in C9ORF72 in Alzheimer's Disease.
    N Engl J Med. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
27. ARTENSTEIN AW , Opal SM
    Proprotein convertases in health and disease.
    N Engl J Med. 2011;365:2507-18.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
28. OKIE S
    Confronting Alzheimer's disease.
    N Engl J Med. 2011;365:1069-72.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through a media sponsorship by Boehringer Ingelheim.

All AMEDEO services are free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Amedeo is a Flying Publisher website.    Design: